Corporate Governance23 Sept 2026, 01:12 pm
Aspira Pathlab Trading Window Closed for Q2 FY27 Results
AI Summary
Aspira Pathlab & Diagnostics Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from October 01, 2026, and will continue until 48 hours after the declaration of the financial results for the half-year ended September 30, 2026. The specific date for the Board Meeting to approve these results will be communicated later. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading.
Key Highlights
- Trading window closed from October 01, 2026.
- Closure is for Q2 FY27 financial results announcement.
- Applies to designated persons and immediate relatives.
- In compliance with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from ASPIRA